A — Agilent Technologies Balance Sheet
0.000.00%
- $30.30bn
- $32.20bn
- $6.51bn
- 93
- 29
- 75
- 72
Annual balance sheet for Agilent Technologies, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,441 | 1,575 | 1,053 | 1,590 | 1,329 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,038 | 1,172 | 1,405 | 1,391 | 1,471 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,415 | 3,799 | 3,778 | 4,186 | 3,959 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,020 | 1,123 | 1,250 | 1,424 | 1,955 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 9,627 | 10,705 | 10,532 | 10,763 | 11,846 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,467 | 1,708 | 1,861 | 1,603 | 1,895 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 4,754 | 5,316 | 5,227 | 4,918 | 5,948 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 4,873 | 5,389 | 5,305 | 5,845 | 5,898 |
Total Liabilities & Shareholders' Equity | 9,627 | 10,705 | 10,532 | 10,763 | 11,846 |
Total Common Shares Outstanding |